Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc N.MMED.WR


Primary Symbol: MNMD Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

Bullboard (NDAQ:MNMD)

View:
Post by TheTanManon Nov 20, 2020 2:38pm

Smell that?

Smell of fresh squeezed Shroom Shorts. Mmm stinkay
Post by Nobuckon Nov 19, 2020 8:56am

Another green Day?

Tons of momentum in the markets rn!
Comment by manymoneyon Nov 17, 2020 7:56pm

RE:Warrants

MMED has conditions on the warrants , 10 days trading over $1.13 the company can call the warrants , force expiry....MMED has the option to do this , some companies call warrants , some don't . If ...more  
Comment by tricHOMEson Nov 16, 2020 7:18pm

RE:RE:RE:Just read and use logic

Agreed. This one can take off! 
Post by oilcanharryon Nov 16, 2020 6:38pm

Warrants

With the share price today closing over 1.40 now puts the trading warrants into the money. As the stock price continues to rise. The warrants will be gaining value also. I thinks warrants are a good ...more  
Comment by pp19888on Nov 16, 2020 6:25pm

RE:RE:Just read and use logic

Don't use the logic , just buy the hype. This is going to touch 5  before any pullback. 
Comment by SouthernTierTomon Nov 16, 2020 4:46pm

RE:Just read and use logic

Too late for logic knowsbet! This puppy worrth over 1/2 BILLION CAD...so sweeeeet! Could you imagine taking this to the tank and asking 50M for 10% - LOL O'Sancky would run you off the stage ...more  
Post by knowsbeston Nov 16, 2020 11:59am

Just read and use logic

company, has received a positive response on its protocol design for a Phase 2a Positive  response on a design ? give us a break ..ha..haa. Not an approval . MindMed has also successfully ...more  
Post by TheTanManon Nov 16, 2020 11:34am

Good time to short this

We need some idiots to try here. So they get squeezed into oblivion ;)
Post by knowsbeston Nov 16, 2020 10:23am

Be very careful and use the left part of your brain

Acording to some people with close knowledge of the company are aware, and are trying to avoid becoming the target of regulatory interventions.
Post by knowsbeston Nov 16, 2020 9:38am

Use your "LOgic " and read between the lines

This company is a scam . It is so clear to experience investors . Stay tuned for some more exposure from reliable sources in Europe and USA . "Make money don loose money "
Post by PsilocybinAlphaon Nov 16, 2020 7:53am

MindMed Provides Updates on Trials, Interim Results Q1 2021

Full news here Your Brief   MindMed provides an update on its Phase 2a Proof of Concept study evaluating microdoses of LSD for the treatment of Adult ADHD   The Company ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities